Gilead Sciences
GILD
#129
Rank
C$207.92 B
Marketcap
C$167.57
Share price
-1.14%
Change (1 day)
33.72%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.14

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.01. In 2024 the company made an earnings per share (EPS) of C$0.53 a decrease over its 2023 EPS that were of C$6.29.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.141639.66%
2024C$0.53-91.65%
2023C$6.2923.98%
2022C$5.07-25.86%
2021C$6.844850%
2020C$0.14-97.64%
2019C$5.860.9%
2018C$5.8118.71%
2017C$4.89-64.88%
2016C$13.93-18.45%
2015C$17.0955.28%
2014C$11.00296.02%
2013C$2.7817.89%
2012C$2.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$18.01 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$19.81 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.87-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$6.18-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.19 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.38-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.43 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$28.36 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.50 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA